Vitamin and mineral deficiency and glucose metabolism - A review

e-SPEN Journal

Volumn 8, Issue 3, 2013, Pages

  Carneiro, Glaucia ^a   Laferrère, Blandine ^b   Zanella, Maria Teresa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Glucose metabolism; Mg; Minerals; T2DM; Vitamins deficiency; Zn

Indexed keywords

CALCIUM; COLECALCIFEROL; MAGNESIUM; VITAMIN D; ZINC;

DIET SUPPLEMENTATION; GLUCOSE METABOLISM; HUMAN; HYPOMAGNESEMIA; MAGNESIUM DEFICIENCY; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 84878178728     PISSN: None     EISSN: 22128263     Source Type: Journal    
DOI: 10.1016/j.clnme.2013.03.003     Document Type: Review

References (50)

1. Martini L.A., Catania A.S., Ferreira S.R. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev 2010 Jun, 68(6):341-354.
2. NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Consens State Sci Statements 2006 May 15-17, 23(2):1-30.
3. American Diabetes Association Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 2009, 32(Suppl. 1):S62-S67.
4. Ford E.S., Ajani U.A., McGuire L.C., Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005 May, 28(5):1228-1230.
5. Scragg R., Sowers M., Bell C. Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 Dec, 27(12):2813-2818.
6. Pittas A.G., Dawson-Hughes B., Li T., Van Dam R.M., Willett W.C., Manson J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006 Mar, 29(3):650-656.
7. Liu S., Song Y., Ford E.S., Manson J.E., Buring J.E., Ridker P.M. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005 Dec, 28(12):2926-2932.
8. Isaia G., Giorgino R., Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001 Aug, 24(8):1496.
9. Scragg R., Holdaway I., Singh V., Metcalf P., Baker J., Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res ClinPract 1995 Mar, 27(3):181-188.
10. McGill A.T., Stewart J.M., Lithander F.E., Strik C.M., Poppitt S.D. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008 Jan 28, 7:4.
11. Baynes K.C., Boucher B.J., Feskens E.J., Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997 Mar, 40(3):344-347. Erratum in: Diabetologia 1997 Jul; 40(7):870.
12. Lopez-Ridaura R., Willett W.C., Rimm E.B., Liu S., Stampfer M.J., Manson J.E., et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004 Jan, 27(1):134-140.
13. Song Y., Manson J.E., Buring J.E., Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004 Jan, 27(1):59-65.
14. Kao W.H., Folsom A.R., Nieto F.J., Mo J.P., Watson R.L., Brancati F.L. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999 Oct 11, 159(18):2151-2159.
15. Meyer K.A., Kushi L.H., Jacobs D.R., Slavin J., Sellers T.A., Folsom A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000 Apr, 71(4):921-930.
16. Ma J., Folsom A.R., Melnick S.L., Eckfeldt J.H., Sharrett A.R., Nabulsi A.A., et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis risk in communities study. J ClinEpidemiol 1995 Jul, 48(7):927-940.
17. Guerrero-Romero F., Rascón-Pacheco R.A., Rodríguez-Morán M., de laPeña J.E., Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008 Jun, 38(6):389-396.
18. Mather H.M., Nisbet J.A., Burton G.H., Poston G.J., Bland J.M., Bailey P.A., et al. Hypomagnesaemia in diabetes. Clin Chim Acta 1979 Jul 16, 95(2):235-242.
19. Montagnana M., Lippi G., Targher G., Salvagno G.L., Guidi G.C. Relationship between hypomagnesemia and glucose homeostasis. Clin Lab 2008, 2008(54):169-172.
20. Dong J.Y., Xun P., He K., Qin L.Q. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011 Sep, 34(9):2116-2122.
21. Singh R.B., Niaz M.A., Rastogi S.S., Bajaj S., Gaoli Z., Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am CollNutr 1998 Dec, 17(6):564-570.
22. Jansen J., Karges W., Rink L. Zinc and diabetes-clinical links and molecular mechanisms. J Nutr Biochem 2009 Jun, 20(6):399-417.
23. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007 Jun, 92(6):2017-2029. Review.
24. Avenell A., Cook J.A., MacLennan G.S., McPherson G.C. RECORD trial group. Vitamin D supplementation and type 2 diabetes: a sub study of a randomized placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009 Sep, 38(5):606-609.
25. Mooren F.C., Krüger K., Völker K., Golf S.W., Wadepuhl M., Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes ObesMetab 2011 Mar, 13(3):281-284.
26. de Lordes Lima M., Cruz T., Pousada J.C., Rodrigues L.E., Barbosa K., Canguçu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998 May, 21(5):682-686.
27. Song Y., He K., Levitan E.B., Manson J.E., Liu S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 2006 Oct, 23(10):1050-1056.
28. Rodríguez-Morán M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003 Apr, 26(4):1147-1152.
29. Johnsen S.P., Husted S.E., Ravn H.B., Stødkilde-Jørgensen H., Peltz-Andresen E., Christensen C.K. Magnesium supplementation to patients with type II diabetes. UgeskrLaeger 1999 Feb 15, 161(7):945-948.
30. de Valk H.W., Verkaaik R., van Rijn H.J., Geerdink R.A., Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med 1998 Jun, 15(6):503-507.
31. Hussain S.A., Khadim H.M., Khalaf B.H., Ismail S.H., Hussein K.I., Sahib A.S. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J 2006 Oct, 27(10):1483-1488.
32. Al-Maroof R.A., Al-Sharbatti S.S. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J 2006 Mar, 27(3):344-350.
33. Oh H.M., Yoon J.S. Glycemic control of type 2 diabetic patients after short-term zinc supplementation. Nutr Res Pract 2008, 2(4):283-288. Winter.
34. Czernichow S., Couthouis A., Bertrais S., Vergnaud A.C., Dauchet L., Galan P., et al. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J ClinNutr 2006 Aug, 84(2):395-399.
35. Anderson R.A., Roussel A.M., Zouari N., Mahjoub S., Matheau J.M., &Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am CollNutr 2001, 20:212-218.
36. Gunasekara P., Hettiarachchi M., Liyanage C., Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes MetabSyndr Obes 2011 Jan 26, 4:53-60.
37. Roussel A.M., Kerkeni A., Zouari N., Mahjoub S., Matheau J.M., Anderson R.A. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am CollNutr 2003, 2003(22):316321.
38. Cunningham J.J., Fu A., Mearkle P.L., Brown R.G. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism 1994 Dec, 43(12):1558-1562.
39. Palomer X., Gonzalez-Clemente J.M., Blanco-Vaca F., Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008, 10:185-197.
40. Norman A.W., Frankel J.B., Heldt A.M., Grodsky G.M. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209:823-825.
41. Sergeev I.N., Rothen W.B. 1,25-dihydroxivitamin D3 evokes oscillations of intracellular calcium in a pancreatic ß-cell line. Endocrinology 1995, 136:2852-2861.
42. Sales C.H., PedrosaLde F. Magnesium and diabetes mellitus: their relation. Clin Nutr 2006, 25:554-562.
43. Tonga S., Rayssiguier Y., Motta C., Gueux E., Maurois P., Heaton F.W. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol 1989, 257:C270-C276.
44. Paolisso G., Sgambato S., Gambardella A., Pizza G., Tesauro P., Varricchio M., et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992, 55:1161-1167.
45. Barbagallo M., Dominguez L.J., Galioto A., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003, 24:39-52.
46. Coulston L., Dandona P. Insulin-like effect of zinc on adipocytes. Diabetes 1980, 29:665-667.
47. May J.M., Contoreggi C.S. The mechanism of the insulin-like effects of ionic zinc. J. Biol. Chem. 1982, 257:4362-4368.
48. Chimienti F., Devergnas S., Pattou F. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 2006, 119:4199-4206.
49. Dalcanale L., Oliveira C.P., Faintuch J., Nogueira M.A., Rondó P., Lima V.M., et al. Long-term nutritional outcome after gastric bypass. Obes Surg 2010 Feb, 20(2):181-187.
50. Riedt C.S., Schlussel Y., von Thun N., Ambia-Sobhan H., Stahl T., Field M.P., et al. Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr 2007 Apr, 85(4):972-980. Erratum in: Am J Clin Nutr. 2007 Sep; 86(3):808.